Nevro Corp. buy Royal Bank of Canada
Start price
01.12.23
/
50%
€17.20
Target price
01.12.24
€21.13
Performance (%)
-75.12%
End price
02.12.24
€4.28
Summary
This prediction ended on 02.12.24 with a price of €4.28. The BUY prediction by Royal_Bank_of_Canada for Nevro Corp. performed very badly with a performance of -75.12%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Nevro Corp. | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Nevro Corp. diskutieren
Nevro Corp. (NYSE: NVRO) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Ratings data for NVRO provided by MarketBeat
In the thread Trading Nevro Corp.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten